Bellerophon Therapeutics
BLPH
#9685
Rank
HK$3.33 M
Marketcap
HK$0.27
Share price
0.00%
Change (1 day)
-91.06%
Change (1 year)

EPS for Bellerophon Therapeutics (BLPH)

EPS in 2023 (TTM): -HK$9.47

According to Bellerophon Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$9.43. In 2022 the company made an earnings per share (EPS) of -HK$16.21 a decrease over its 2021 EPS that were of -HK$14.65.

EPS history for Bellerophon Therapeutics from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$9.47-41.57%
2022-HK$16.2110.64%
2021-HK$14.65-42.86%
2020-HK$25.6512.67%
2019-HK$22.76-500%
2018HK$5.69-103.53%
2017-HK$161.36-13.75%
2016-HK$187.08-48.13%
2015-HK$360.68882.98%
2014-HK$36.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$39.91-523.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$23.41 148.23%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$23.17-345.64%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.93-226.45%๐Ÿ‡บ๐Ÿ‡ธ USA